Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Prevalence of BP180 and BP230 Autoantibodies in the Serum of Patients With Pruritus Under Immunotherapy

NCT05689463 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT05689463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05689463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Prevalence of BP180 and BP230 Autoantibodies in the Serum of Patients With Pruritus Under Immunotherapy
Lead sponsor
University Hospital, Rouen
Phase
Not applicable
Overall status
Recruiting
Start date
February 23, 2023
Completion date
February 28, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with chronic pruritus for more than 1 month who have received immunotherapy